Enorin 8000 Anti-Xa IU/0.8 ml (SC Injection)
0.8 ml pre-filled syringe: ৳ 650.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Enoxaparin sodium |
| Company | Eskayef pharmaceuticals ltd |
| Also available as |
Indications
- Treatment of deep vein thrombosis
- Treatment of unstable angina and non-Q-wave myocardial infarction
- Prevention of thrombus formation in the extra-corporal circulation during hemodialysis
- Prophylaxis of venous thromboembolic disease in surgical and medical patients
Composition
- 0.2 ml pre-filled syringe contains Enoxaparin Sodium BP 20 mg
- 0.4 ml pre-filled syringe contains Enoxaparin Sodium BP 40 mg
- 0.6 ml pre-filled syringe contains Enoxaparin Sodium BP 60 mg
- 0.8 ml pre-filled syringe contains Enoxaparin Sodium BP 80 mg
Pharmacology
- Low molecular weight heparin with high anti-Xa activity and low anti-IIa or antithrombin activity. Metabolized in the liver.
Dosage
- Subcutaneously 100 anti-Xa lU/kg twice daily for 10 days for deep vein thrombosis
- Subcutaneously 150 anti-Xa lU/kg once daily for 10 days for deep vein thrombosis
- Subcutaneously 100 anti-Xa lU/kg twice daily for 2- 8 days for unstable angina and non-Q-wave myocardial infarction
Administration
- Injecting yourself with Enoxaparin Sodium Syringes
- Instructions on preparing the injection site
- Selecting the dose
- Injecting the medication
- Disposal of used syringe
Interaction
- Recommendation to discontinue agents affecting hemostasis prior to Enorin therapy
Contraindications
- Known hypersensitivity to Enoxaparin Sodium, heparin, or other low molecular weight heparins
Side Effects
- Haemorrhage
- Thrombocytopenia
- Elevations of serum aminotransferase
- Pain and bluish marks at injection sites
Pregnancy & Lactation
- Pregnancy category B
- Unknown excretion in human milk
Precautions & Warnings
- Injection routes
- Administration with caution in conditions with increased potential for bleeding
- Recommendation to measure platelet counts before initiation of treatment
Overdose Effects
- Accidental overdosage may lead to hemorrhagic complications
Therapeutic Class
- Parenteral anti-coagulants
Storage Conditions
- Store in a cool and dry place, protect from light and moisture